- Study of the Effect of Route of Administration of Mesenchymal Stem Cells on Cisplatin-Induced Acute Kidney Injury in Sprague Dawley Rats
-
Moustafa F, Sobh MA, Abouelkheir M, Khater Y, Mahmoud K, Saad MA, Sobh MA
- KMID: 2164164
- Int J Stem Cells.
- 2016 May;9(1):79-89.
- doi: 10.15283/ijsc.2016.9.1.79
BACKGROUND AND OBJECTIVES: Mesenchymal stem cells (MSCs) have been shown to ameliorate cisplatin-induced acute kidney injury (AKI). The present study compares the efficacy of different routes of MSCs administration on... -
- CITED
-
- Close
- SHARE
-
- Close
- Amniotic Fluid-Derived Mesenchymal Stem Cells Cut Short the Acuteness of Cisplatin-Induced Nephrotoxicity in Sprague-Dawley Rats
-
Al-Husseiny F, Sobh MA, Ashour RH, Foud S, Medhat T, El-Gilany , Elghannam , Abdel-Ghaffar H, Saad MA, Sobh M
- KMID: 2164163
- Int J Stem Cells.
- 2016 May;9(1):70-78.
- doi: 10.15283/ijsc.2016.9.1.70
BACKGROUND AND OBJECTIVES: Cisplatin is a nephrotoxic chemotherapeutic agent. So, preventive measures worth to be evaluated. Human amniotic fluid stem cells (hAFSCs) in prevention or amelioration of cisplatin-induced acute kidney... -
- CITED
-
- Close
- SHARE
-
- Close
